SPC233
Búrósúmab
Status:
VeittApplication date:
14.8.2018Application published:
15.9.2018Grant published:
15.3.2021
Max expiry date:
13.2.2033Medicine name:
CrysvitaMedicine for children:
No
Timeline
Today
14.8.2018Application
15.9.2018Publication
15.3.2021Registration
13.2.2033Expires
Marketing license
IS authorization number:
EU/1/17/1262/001-003Date:
26.2.2018
Foreign authorization number:
EU/1/17/1262Date:
19.2.2018
Owner
Name:
Kyowa Kirin Co., Ltd.Address:
1-9-2, Otemachi, Chiyoda-ku, Tokyo 100-0004 JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2128253